Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 2, 2009

Premium

Rick Hockett has been named chief medical officer at Affymetrix, the firm said this week.

Hockett joined Affy in March from Eli Lilly, where he was medical fellow and director of genomic medicine. Prior to Lilly, he spent seven years on staff at the University of Alabama Birmingham Hospital, where he was professor of pathology and head of clinical immunology and molecular diagnostics.


SRU Biosystems last week named Jane Clark and Rick Loomis as senior sales executives for its North American sales division, and appointed Steve Shamah as its director of cell biology.

Clark most recently served as a senior sales executive at VisEn Medical, and previously held sales positions at Amaxa, Affymetrix, and Life Technologies. Loomis was director of industrial sales at Lonza, and has also worked at Genetix, Acea, and PerkinElmer. Prior to joining SRU, Shamah was a senior principal investigator at Archemix. He also held positions at Hydra Biosciences and Phylos.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.